The word "peptide" has been doing a lot of unearned work lately. It appears on skincare bottles, in gym conversations, and in headlines about new diabetes drugs, and in each of those places it seems to mean something slightly different. It doesn't. In chemistry the term is precise and fairly boring, which is exactly what makes it useful: a peptide is a chain of amino acids linked end to end by peptide bonds.
That's the whole definition. Everything interesting — what a given peptide does in a body, whether it's a hormone or a drug or neither, whether anyone should ever take it — sits on top of that structural fact rather than inside it.
Start with amino acids
An amino acid is a small molecule built around a central carbon. Hanging off that carbon are four things: a hydrogen atom, an amino group (–NH2), a carboxyl group (–COOH), and a side chain that varies from one amino acid to the next. The first three are identical across the standard set. The side chain is where all the personality lives.
Twenty amino acids are specified by the standard genetic code, and their side chains span a wide range of chemistry. Glycine's is a single hydrogen atom, making it small and flexible. Cysteine carries a sulfur-containing thiol group that can form a covalent bridge with another cysteine elsewhere in the chain. Leucine and valine are greasy and hydrophobic; lysine and glutamate carry charge at physiological pH. Proline is the odd one, its side chain looping back to bond with its own nitrogen, which puts a rigid kink in whatever chain contains it.
The peptide bond
Join two amino acids and you get the linkage the whole class is named after. The carboxyl group of one reacts with the amino group of the next; a molecule of water leaves, and what remains is a C–N bond known as an amide — in this biological context, a peptide bond. Chemists call the reaction a condensation, because of that departing water.
The bond has a property worth knowing about. Although you'd draw it as a single bond, the electrons are shared with the neighbouring carbon–oxygen double bond, giving the C–N link partial double-bond character. The practical consequence is that the six atoms around each peptide bond are locked into a flat plane and can't rotate freely. A chain of amino acids is therefore not a floppy string — it's a series of rigid plates joined by rotatable hinges, which is precisely why chains fold into reproducible shapes rather than random tangles.
The repeating N–C–C pattern running the length of the chain is called the backbone. The side chains stick out from it. Convention writes a sequence from the free amino end (the N-terminus) to the free carboxyl end (the C-terminus), so a three-residue peptide might be written Gly–Pro–Ala — glycine, then proline, then alanine, in that order and no other.
A chain of amino acids is not a floppy string. It's a series of rigid plates joined by rotatable hinges — which is why proteins fold the same way every time.
— The Backbone editorsPrimary structure, and why order matters
That sequence — the identity and order of the residues — is a molecule's primary structure. It is the only level of structure encoded directly in DNA, and everything above it follows from it. Local stretches of backbone settle into regular patterns like helices and sheets (secondary structure), the whole chain packs into a three-dimensional shape (tertiary), and separate chains sometimes assemble together (quaternary).
Order is not a detail. Swap two residues in a nine-residue hormone and you may have made a molecule that no longer fits its receptor at all — or one that fits a different receptor. This is why the sequences of naturally occurring peptides are conserved so tightly across species, and why the difference between two clinically distinct molecules can come down to a handful of positions.
Where does "peptide" end and "protein" begin?
Here is the honest answer: nowhere in particular. The usual rule of thumb puts the boundary somewhere around fifty residues — shorter chains get called peptides, longer ones proteins — but that number is a convention of usage, not a property of matter. The chemistry is identical on both sides of it. There is no reaction that happens at residue 51.
What people are usually gesturing at with the distinction is behaviour. Short chains tend not to fold into a single stable three-dimensional structure on their own; they're often flexible in solution and adopt a defined shape only when bound to something. Longer chains generally do fold into a compact, stable form with an interior and a surface. That difference is real, but it comes on gradually and there are plenty of exceptions in both directions.
Insulin is the standard illustration. At 51 residues across two chains it sits exactly on the line, and it gets described both ways in the literature depending on who is writing. It has a defined fold and is often called a small protein; it is also, unambiguously, a chain of amino acids joined by peptide bonds. Both descriptions are correct because they are the same description.
Worth being clear about
Because "peptide" names a chemical structure and nothing more, it tells you nothing about whether a given molecule is safe, effective, approved, or appropriate for anyone. Many compounds marketed under that label are investigational — not approved by the FDA, and not dietary supplements either. Questions about your own health belong with a licensed clinician; questions about the evidence base belong to the published literature and ClinicalTrials.gov.
So the next time the word turns up in a headline, it's fair to translate it as: a short chain of amino acids. That's all it asserts. Which one, what it binds to, whether anyone has tested it properly — those are separate questions, and the ones actually worth asking.